BUCUMOLOL HYDROCHLORIDE

Details

Stereochemistry	RACEMIC
Molecular Formula	C17H23NO4.ClH
Molecular Weight	341.83
Optical Activity	( + / - )
Defined Stereocenters	0 / 1
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

Cl.CC1=CC=C(OCC(O)CNC(C)(C)C)C2=C1C=CC(=O)O2

InChI

InChIKey=OQVOZUWFVLLPRL-UHFFFAOYSA-N

InChI=1S/C17H23NO4.ClH/c1-11-5-7-14(16-13(11)6-8-15(20)22-16)21-10-12(19)9-18-17(2,3)4;/h5-8,12,18-19H,9-10H2,1-4H3;1H

HIDE SMILES / InChI

Molecular Formula	ClH
Molecular Weight	36.461
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Molecular Formula	C17H23NO4
Molecular Weight	305.3688
Charge	0
Count

Stereochemistry	RACEMIC
Additional Stereochemistry	No
Defined Stereocenters	0 / 1
E/Z Centers	0
Optical Activity	( + / - )

Description
Sources: http://www.genome.jp/dbget-bin/www_bget?dr:D01492
Curator's Comment: Description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/4148384

Bucumolol is a beta-adrenergic antagonist. It can be used in the treatment of myocardial ischemia and hypertension.

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Beta-1 adrenergic receptor 163 Target ID: CHEMBL213 Sources: http://www.genome.jp/dbget-bin/www_bget?dr:D01492	Antagonist 2849
Beta-2 adrenergic receptor 209 Target ID: CHEMBL210 Sources: http://www.genome.jp/dbget-bin/www_bget?dr:D01492	Antagonist 2849

Conditions

Condition	Modality	Highest Phase	Product
Angina pectoris 110 Sources: http://www.ncbi.nlm.nih.gov/pubmed/24799	Primary	Preclinical	Unknown Approved Use Unknown
Hypertension 575 Sources: http://www.ncbi.nlm.nih.gov/pubmed/6117610	Primary	Basic research	Unknown Approved Use Unknown
Ventricular arrhythmia 50 Sources: http://www.ncbi.nlm.nih.gov/pubmed/44326	Primary	Basic research	Unknown Approved Use Unknown
Myocardial ischemia 14 Sources: http://www.ncbi.nlm.nih.gov/pubmed/6119377	Primary	Basic research	Unknown Approved Use Unknown

PubMed

Title	Date	PubMed
Antiarrhythmic activity of dextro- and levo-isomers of 5-methyl-8-(2-hydroxy-3-t-butylamino-propoxy) coumarin hydrocholoride (bucumolol), a beta-adrenergic blocking agent, on aconitine-induced atrial and ouabain-induced ventricular arrhythmias in dogs.	1979-12	44326

Patents

Sample Use Guides

In Vivo Use Guide

Unknown

Route of Administration: Oral

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Mon Mar 31 21:19:52 GMT 2025` Edited by `admin` on `Mon Mar 31 21:19:52 GMT 2025`
Record UNII	U2Z7867QU7
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

BUCUMOLOL HYDROCHLORIDE

Common Name

English

BUCUMAROL

Preferred Name

English

BUCUMOLOL HYDROCHLORIDE [JAN]

Common Name

English

BUCUMOLOL HYDROCHLORIDE [MI]

Common Name

English

8-(2-HYDROXY-3-(TERT-BUTYLAMINO)PROPOXY)-5-METHYL-CHROMEN-2-ONE HYDROCHLORIDE

Systematic Name

English

CS-359

Code

English

Bucumolol hydrochloride [WHO-DD]

Common Name

English

8-(3-(TERT-BUTYLAMINO)-2-HYDROXYPROPOXY)-5-METHYLCOUMARIN HYDROCHLORIDE

Systematic Name

English

Code System Code Type Description

EVMPD

SUB21960